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A B S T R A C T
Background
Breast Care Nurses (BCNs) are now established internationally, predominantly in well resourced healthcare systems. The role of BCNs
has expanded to reflect the diversity of the population in which they work, and the improvements in survival of women with breast
cancer. Interventions by BCNs aim to support women and help them cope with the impact of the disease on their quality of life.
Objectives
To assess the effectiveness of individual interventions carried out by BCN’s on quality of life outcomes for women with breast cancer.
Search methods
We searched the Cochrane Breast Cancer Group Specialised Register and the Cochrane Central Register of Controlled Trials (15 January
2007). We also searched MEDLINE (1966 to September 2006), CINAHL (1982 to September 2006), EMBASE (1980 to September
2006), British Nursing Index (1984 to September 2006), CancerLit (1961 to September 2006), PsycInfo (1967 to September 2006),
Library and Info Science Abstracts (LISA) (1969 to September 2006), Dissertation Abstracts International (only available 2005 to
September 2006). We contacted authors as appropriate.
Selection criteria
Randomised controlled trials assessing the effects of interventions carried out by BCN’s on quality of life outcomes, for women with
breast cancer.
Data collection and analysis
Two authors independently assessed relevant studies for inclusion and undertook data extraction and quality assessment of included
studies.
Main results
We included five studies, categorised into three groups. Three studies assessing psychosocial nursing interventions around diagnosis
and early treatment found that the BCN could affect some components of quality of life, such as anxiety and early recognition of
depressive symptoms. However, their impact on social and functional aspects of the disease trajectory was inconclusive. Supportive
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care interventions during radiotherapy was assessed by one study which showed that specific BCN interventions can alleviate perceived
distress during radiotherapy treatment, but did not improve coping skills, mood or overall quality of life. One study assessed nurse-led
follow-up interventions in which no statistically significant difference was identified for main demographic variables, satisfaction with
care, access to medical care or anxiety and depression.
Authors’ conclusions
There is limited evidence at this time to support the contention that interventions by BCNs assist in the short-termwith the recognition
and management of psychological distress for women with breast cancer. Further research is required before the impact of BCNs on
aspects of quality of life for women with breast cancer can be known.
P L A I N L A N G U A G E S U M M A R Y
Specialist breast care nurses for supportive care of women with breast cancer
Breast cancer is a complex disease which has seen survival for women improve over the last 20 years. Many of these improvements are
linked to treatment advances, improved screening and a multiprofessional approach to its management. Breast Care Nurses (BCNs)
work within this multiprofessional environment providing a range of interventions including support, information, patient advocacy
and general liaison among the various members of the healthcare team. The objective of this review was to assess the effectiveness of
individual interventions carried out by BCNs on quality of life outcomes for women with a diagnosis of breast cancer. We reviewed
five studies which met the criteria for this systematic review. These involved a range of interventions and outcome measurements, and
included women of various ages and in various stages of breast cancer assessment and treatment. These studies also used many different
methods of reporting statistical findings and for this reason, the results of the studies could not be combined. Despite limited evidence
to support their BCN role, one study which looked at follow up by the BCN compared to a doctor concluded that there were no
differences for either group in terms of satisfaction with care or the ability of the healthcare provider to identify anxiety and depression.
Another study showed that specific BCN interventions can alleviate perceived distress for women undergoing radiotherapy treatment
however this did not have any impact on coping skills, mood or overall quality of life.
Generally speaking, this review found limited evidence to identify the components of the BCNs role which impact on a woman’s quality
of life but acknowledge that the nature of their work, provided within a multiprofessional team, serves to complement the team as a
whole rather than highlighting the impact of the BCN alone. Further research is, however, needed which addresses the impact that
BCNs may have on aspects of quality of life for women with breast cancer.
B A C K G R O U N D
Breast cancer is a significant health problemworldwide, and a com-
plex disease both physically and psychologically (WHO 2005).
Dealing with the many challenges relating to a diagnosis of breast
cancer, such as lengthy treatments and trying to combine recov-
ery with family and work commitments, can have a significant
and negative impact on women ( Fallowfield 2002; Schultz 2005;
Spagnola 2003). Following diagnosis of breast cancer an individ-
ual’s quality of life can be challenged physically, psychologically
and functionally. Depression and anxiety may result from the dis-
tress of diagnosis, fear of a life-threatening disease and tumour re-
currence. Breast surgery may impact psychologically on a woman’s
body image and sexuality. Side effects such as nausea and vom-
iting: hair loss and fatigue; secondary lymphoedema; symptoms
associated with therapy-induced menopause, such as hot flushes
and emotional lability are just some of the physical consequences
of breast cancer treatments. To the individual patient, therefore,
breast cancer is not only a medical problem, but also one which
has serious psychological, emotional and social impact. Effective
management requires a professional and holistic approach.
Maguire 1978 and Maguire 1983 were the first to identify the
specific emotional and psychological needs of women diagnosed
with breast cancer and the need to offer both psychological as well
as physical care to aid recovery. Their work laid the foundation for
the development of the role of Breast Care Nurses (BCNs) in the
United Kingdom. Other countries have also embraced this role.
In North America, Australia and Scandinavia, BCNs or Specialist
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Breast Care Nurses (SBCNs) have been developing their roles over
the past 20 years. Various educational models and postgraduate
programmes have evolved to prepare BCNs for their role (Eicher
2006; EUSOMA 2007; RCN 2007).
The roles and titles of BCNs can vary across continents, and some
work has been done to define the role better. Yates 2007 consulted
stakeholders and undertook a focussed review of existing litera-
ture to develop competency standards for Australian BCNs. They
define the BCN as:
“a registered nurse who applies advanced knowledge of the health
needs, preferences and circumstances of women with breast cancer
to optimise the individual’s health and well-being at various stages
across the continuum of care, including diagnosis, treatment, re-
habilitation and palliative care”
Illuminating and quantifying what the BCNs do is difficult due to
the variations in practice settings in which they are employed and
training opportunities available. Yates 2007 identified five main
domains of competency for BCNs. These are supportive care,
collaborative care, co-ordinated care, information provision and
education and clinical leadership.
Interventions which provide supportive care are not exclusive to
nursing, hence the difficulties in establishing the impact of nurse-
led interventions on patient outcomes (Corner 2003). Despite
this, there is research evidence that the BCN contributes to im-
provements in outcomes for women by providing information
and support which promote continuity of care (Redman 2003;
Yates 2007). Women themselves have reported positive outcomes
from their interactions with the BCN. In the study by Gray 2002,
women found supportive care by the BCN to be paramount in
improving their illness experience and quality of life. Likewise, in
interviews with women with breast cancer conducted by Halkett
2006, interviewees repeatedly emphasised the importance of the
role of the BCN in providing support through communication,
establishing rapport and an awareness of their needs. The avail-
ability of the BCN and the provision of reassurance and practi-
cal information was seen to be particularly useful. The Special-
ist Breast Nurse Project Team (NBCCSBNPT 2003) interviewed
176 women and found that they viewed BCNs as good commu-
nicators who were skilled in explaining issues and who provided a
significant link between them and their doctors (96%) and com-
munity health workers (86%). Continuity of care was rated as a
major benefit by 88% of these women and 97% reported that they
benefited from ongoing contact with the BCN.
Supportive care can be variously defined and is frequently inter-
preted as a vague umbrella term including anything from an ev-
idence-based intervention to a bedside conversation. In terms of
the BCN role, supportive care interventions are aimed at improv-
ing women’s quality of life. This supportive role reflects the ability
of the BCN to identify multiple physical, psychological, social,
sexual, cultural and spiritual needs of individual breast cancer pa-
tients. Needs identification at all stages of the illness, implemen-
tation of evidence-based interventions and psychosocial support
in a responsive and flexible manner, provided in conjunction with
anti-cancer treatment, are key (NBCCSBNPT 2003; RCN 1999;
RCN 2002a; Yates 2007).
Currently, BCNs are mainly supported within better resourced
healthcare systems where they are often the primary contact for
women following a diagnosis of breast cancer. Working as part of
a breast team is central to the work of BCNs and, as such, they are
a regular feature of the multidisciplinary healthcare team (Amir
2004; SIGN 2005). National and clinical guidelines recommend
multidisciplinary teams (MDTs) as the best way to manage breast
cancer and maximise outcomes (Grunfeld 2005; NICE 2002).
The effectiveness of these teams comes from common goals and
understanding among members as to the impact of the illness on
eachwoman, recognisingher circumstances, feelings, concerns and
preferences for treatment and the contribution each can make (
Mileshkin 2006). The BCN is awell respected andwell established
entity within these teams, and has been shown to impact positively
on the overall quality of clinical care provided towomen (P=0.003)
and to exert a positive influence on the work of their teams and
their medical colleagues (Haward 2003)
The aim of this systematic review was to examine a range of quality
of life outcome indicators (physical, psychological and psychoso-
cial) in order to establish changes in outcomes for women which
can be attributed to BCN supportive care interventions thereby
informing the future development of the BCN role.
O B J E C T I V E S
To assess the effectiveness of individual interventions carried out
by BCNs on quality of life outcomes for women with a diagnosis
of breast cancer.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs)
Types of participants
Women with a diagnosis of breast cancer. Eligible participants in-
cluded women of any age, stage of disease, receiving any treatment
modality and in any setting including inpatients, outpatients and
primary care
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Types of interventions
Breast Care Nurses (BCNs). A BCN is defined for the purposes of
this review as a registered nurse with a qualification or specialist
knowledge in Breast Care (NHS 2005). Examples of comparisons
are as follows:
1. BCN versus no BCN
2. BCN versus other supportive care interventions
3. BCN versus other care
Types of outcome measures
Women reported levels of physical, psychological, and psychoso-
cial indices of quality of life measured using reliable and valid
assessment tools. Quality of life is a broad term which is used
widely in research to encompass a variety of factors that impact on
women’s wellbeing. Included studies used a number of different
validated tools
Quality of life indicators assessed in this review include any of the
following:
• menopausal symptoms;
• physical and functional well-being;
• fatigue;
• lymphoedema;
• nausea;
• vomiting;
• anxiety and depression;
• coping;
• body image;
• sexual functioning;
• social and financial.
Secondary outcome measures include:
• economic data;
• service provision.
Search methods for identification of studies
Electronic searching
The group searched the Cochrane Breast Cancer Group Spe-
cialised Register and the Cochrane Central Register of Controlled
Trials on 15 January 2007.
We applied the MEDLINE search strategy Appendix 1 (Sil-
ver Platter; Edition 2003) - based on the Dickersin strategy
(Dickersin1994) for RCTS, the Cochrane Breast Cancer Group’s
strategy for the identification of populations with ’breast neo-
plasms’ (1966-2006) and the following key terms to identify sup-
portive care interventions by Specialist Breast Care Nurses:
1. exp breast neoplasms/nu;
2. exp nurse clinicians;
3. exp nurse’s role;
4. exp oncologic nursing;
5. exp nurse practitioner;
6. or/1-5;
7. (breast adj3nurs$).ti,ab,sh;
8. or/6-7;
9. support$ adj/5 (care or caring).
We searched the following databases to obtain relevant studies for
this review and adapted different search strategies according to the
query requirements of individual databases. We did not restrict
our search by year or language of papers.
CINAHL (1982 to September 2006) (Appendix 2)
EMBASE ( 1980 to September 2006) (Appendix 3)
PsycInfo (1967 to September 2006) (Appendix 4)
BRITISH NURSING INDEX (1984 to September 2006) (
Appendix 5)
CancerLIT (1961 to September 2006) - Indexed by MEDLINE
Library and Info Science Abstracts (LISA) 1969 to September
2006 (Appendix 6)
Physician Data Query (PDQ) available through the National
Cancer Institute web site at:http://www.cancer.gov/search/clini-
cal_trials/ - Indexed by MEDLINE to September 2006
Meeting abstracts available through the U.S. National Li-
brary of Medicine Gateway search available at: http://gate-
way.nlm.nih.gov/gw/cmd to September 2006
We searched the ISI Web of Knowledge database for relevant ab-
stracts from conference proceedings to September 2006.
Hand searching
We did not undertake hand searching, due to limited time and re-
sources. Results of handsearching of Cancer nursing (1995-2000)
and Supportive Care in Cancer (1993-2000) are included in the
Cochrane Central Register of Controlled Trials.
Experts in the field
We contacted one author of an identified study for further infor-
mation.
Limitations
SIGLE (The system for information onGrey Literature in Europe)
was not available to search andDissertationAbstracts International
(1961- present) was only available from 2005 to September 2006.
Data collection and analysis
1. Assessment of methodological quality
Two authors (SC, CK) independently assessed all the titles and
abstracts retrieved by the electronic searches to identify potentially
relevant studies. We entered references of selected studies into a
table and requested a full text copy. Pairs of reviewers (SC & ID,
CK & KL) agreed by discussion which studies met the inclu-
sion criteria. Two authors (SC and CK) assessed and graded the
methodological quality of included studies using a standardised
quality scale by Jadad 1996. The authors used the Cochrane Col-
laboration criteria to assess allocation concealment (A- adequate,
B - unclear, C- inadequate, D- not used). See Table 1 for included
studies.
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2. Data extraction:
Key information was extracted by the authors (SC & CK, ID &
KL) on a standardised data extraction form to include the
following.
a. General Information
Author, title, source, contact address, year of study, country of
study, language of
publication, year of publication.
b. Trial characteristics
Design (randomised or non-randomised), randomisationmethod,
manner of
recruitment, sampling, duration of intervention period, length of
follow-up, reason
and number of dropouts, adverse events.
c. Patients
Stage of disease, inclusion criteria, age.
d. Intervention
Detailed description of the controlled intervention, mode, inten-
sity, duration.
e. Outcomes
Specific outcome reported, assessment instrument used, scoring
range.
f. Economic data
Cost.
g. Service provision
Resource allocation.
We produced two tables, one to identify the included studies and
the other detailing the characteristics of all excluded studies. See
’Characteristics of included studies’ and ’Characteristics of ex-
cluded studies’.
3. Combining data
The heterogeneity of studies both with regard to the diversity of
interventions assessed and outcomes measures used made a quan-
titative pooling of data inappropriate. The main outcome mea-
sures are in the form of continuous data, reporting a comparison
between treatment and control group levels of psychological dis-
tress and/or quality of life. A variety of validated tools was used
to measure the outcomes within studies, and this review therefore
presents a narrative synthesis of the different interventions identi-
fied and the main results of the included studies.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies; Characteristics of ongoing studies.
We reviewed a total of 1,441 abstracts. Of these, we retrieved 34
full text articles for further examination.
We excluded 16 articles because they were not a nursing interven-
tion (Allen 2002; Ambler 1999; Bordeleau 2003; Brown 2002;
Giese-Davis 2002; Goodwin 2003; Helgeson 1999; Maguire
1985; Rolnick 1999; Samarel 2002; Sandgren 2000; Sandgren
2003; Targ 2002; Vos 2004; Williams 2004; Wyatt 2004). We
excluded another eight studies because the outcomes did not meet
inclusion criteria (Cimprich 1993; Hughes 2000: Kolcaba 1999;
Larsson 1992; Lev 2001; Mock 1997; Motzer 1997; Sameral
1998); two more studies provided insufficient data to extract re-
sults despite contacting authors (Cleeland 1996; Ironson 2002 ).
See table ’Characteristics of excluded Studies’ for more informa-
tion.
One study (Arving 2006) met the inclusion criteria, but presented
insufficient data to extract results. Contact with the study authors
established that this paper is not yet published. See ’Characteristics
of on-going studies’ for more information.
Seven articles were eligible for inclusion in the review. These re-
ported on five primary studies which were subsequently included
in the review (Koinberg 2004;Maguire 1980;McArdle 1996; Ritz
2000; Wengstrom 1999). As Maguire 1980 and Maguire 1983
report on the same study, this data has been combined under the
primary publication Maguire 1980. In addition,Wengstrom 1999
andWengstrom 2001 also reported on the same study.We consid-
ered data presented in the 1999 paper to be of primary significance
for this review See ’Characteristics of included Studies’ for more
information.
We categorised the included studies into three groups, according
to the intervention assessed.
1. Psychosocial nursing interventions around diagnosis and early
treatment (three studies, 654 breast cancer patients) (Maguire
1980; McArdle 1996; Ritz 2000).
2. Supportive Care interventions during radiotherapy (one study,
134 breast cancer patients) (Wengstrom 1999).
3. Nurse-led follow-up interventions (one study, 264 breast cancer
patients) (Koinberg 2004).
1. Psychosocial nursing interventions around diagnosis and
early treatment
Psychological morbidity is recognised as a significant consequence
of a diagnosis of breast cancer WHO 2005. BCNs are widely
involved in supporting women with breast cancer from the point
of diagnosis throughout the disease trajectory. These roles have
become fully established and embedded in many practices.
Maguire 1980 conducted aRCTtodeterminewhether counselling
by a specialist nurse prevented the psychiatric morbidity associated
with mastectomy and breast cancer. This study randomised 172
womenwith breast cancer, whohad amodified radicalmastectomy
and full axillary clearance, to receive a counselling intervention
carried out by the nurse within a few days of surgery and thereafter
every two months at home for 12-18 months, or routine care from
a surgical unit doctor. They also wanted to determine if a specialist
nurse improved the physical and social recovery of women and
helped them to adapt to the breast loss following mastectomy for
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breast cancer. These early studies sought to identify the problems
encountered bywomenwith breast cancer, and the role of the nurse
in helping to alleviate them. They report data relating to the role of
the specialist nurse in preventing psychiatric morbidity following
mastectomy (Maguire 1980) and the role of the specialist nurse
in reducing physical disability and improving social recovery after
mastectomy (Maguire 1983).
McArdle 1996 conducted a prospective RCT to evaluate the effect
of support from a nurse specialising in breast care and a voluntary
support organisation on prevalence of psychological morbidity
after surgery for breast cancer. This study randomly assigned 272
women prior to surgery to one of four groups:
a) routine support from ward staff and an information booklet
(Understanding cancer of the breast: BACUP);
b) as per group A plus support from (BCN);
c) as per group A plus support from a voluntary organisation (Tak
Tent);
d) as per group A plus support from BCN and the voluntary
organisation.
Prevalence of psychologicalmorbiditywas assessed using self rating
scales: a 28-item general health questionnaire and its subscales,
and the hospital anxiety and depression scale. Measurements were
made at the first postoperative clinic visit and at 3, 6, and 12
months after surgery.
Ritz 2000 compared whether standard medical care (SMC) or
SMC plus the additional input from an Advanced Practice Nurse
(APN) could improve quality of life outcomes while decreasing
overall costs. In this study, 210 women were randomly assigned to
one of two possible groups.
• SMC
• SMC plus an intervention delivered by an APN within two
weeks of diagnosis of breast cancer and up to 12 months. The
APN was qualified with a Masters’ degree in nursing and had in-
depth knowledge and skills in the care of this group. The
intervention following diagnosis provided written and verbal
information about breast cancer, what to expect in consultations
with physicians, decision-making support, answering questions
and the presence of the APN at consultation to support the
women. Subsequent contact was provided in a variety of settings,
including hospital, telephone and community, to reinforce
information, provide continuity and offer ongoing support.
2. Supportive Care interventions during radiotherapy
We foundoneRCT(Wengstrom 1999)which assessed the effect of
a nursing intervention for women receiving curative radiotherapy
on their subjective distress, side effects and quality of life. The
goals of the intervention were to enhance and restore the women’s
ability for self-care.
This study randomised 134 women with breast cancer to standard
nursing care (SNC) or SNCplus a structurednursing intervention.
• SNC: This included a group information session for
women containing information about treatment, routines and
side effects, and contact with a nurse during the treatment period
(approx. 15 minutes was spent with each woman).
• SNC plus a structured nursing care intervention: This
involved an additional individual session for each woman
focusing on encouraging self care actions to minimise, prevent or
alleviate side effects of therapy, psychological support, education
and guidance, and referral to the wider multi-professional team.
3. Nursing led follow-up interventions
Rojas 2000 questioned the value of routine follow ups with fre-
quent visits to a breast cancer medical specialist. Specialist nurses
working in the field of breast cancer are increasingly involved in
this type of intervention. We found one RCT (Koinberg 2004)
which compared routine follow up of breast cancer patients by a
specialist oncologist/surgeon within a hospital setting to follow up
by demand, managed by an experienced nurse specialist, working
within a hospital setting.
This study randomly assigned 264 breast cancer patients with stage
1 or 2 disease to one of two possible follow-up practices within a
large cancer centre.
• Standard follow-up care: The patient was examined by an
oncologist or surgeon four times per year for the first two years,
bi-annually for five years and yearly thereafter, plus yearly
mammography.
• Intervention: A Nurse Specialist saw the patient three
months post-surgery. The Nurse Specialist worked within a large
cancer centre and had in-depth knowledge and skills in the care
of this patient group. The Nurse Specialist gave the women
information about recurrence, advice, and contact details, and
they were asked to contact the nurse if there were concerns or
symptoms related to the breast cancer. The Nurse also co-
ordinated yearly mammography.
Risk of bias in included studies
Using the framework provided by Jadad 1996 for assessing study/
design and reporting quality, we graded all the studies accordingly
(0 was considered the weakest and 5 the strongest). See Additional
Table 1 ’Quality assessment’ for more information.
• Described as randomised 0/1
• Method of randomisation described and appropriate 0/1
• Described as double blind 0/1
• Method of double blinding described and appropriate 0/1
• Withdrawals and dropouts described 0/1
• One point deducted if method of randomisation described
was inappropriate 0/-1
• One point deducted if study described as double blind, but
method of blinding inappropriate 0/-1
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The Jadad framework and the assigning of a quantitative score
were not representative of the overall quality of a paper, particularly
as it is not possible to blind these types of interventions. Despite
this, none of the studies could be considered high quality.
1. Psychosocial nursing interventions around diagnosis and
early treatment
Maguire 1980 graded 2
The authors claim the groups were closely matched on variables
including pre-operative psychological morbidity, stage of disease,
other treatments, age, marital status, social class and other stressful
events, although no specific details were given. Assessments were
completed on 152 women; of the 20 remaining, drop out was
explained for eight.
McArdle 1996 graded 1
The authors reported levels of attrition (95), but it was unclear
if those who dropped out were included in the analysis. This was
an important consideration, particularly as their was inequality
of loss to follow up between the different groups. At 12 months,
the loss was 24% for routine care compared to 6% (nurse only),
8% (voluntary organisation only) and 16% (combined). There
may have been differences between these groups and those who
remained in the study. Consent was not obtained prior to ran-
domisation, with some women unwilling to receive the support
offered, and this may have contributed to the large attrition rate.
No one refused to see the nurse, but 12 participants did not want
to be approached by the voluntary organisation (VO). Of those
who did have contact with the VO, a further 17 did not wish
further contact. It is important to acknowledge that the timing of
the interventions and, indeed, the function of Tak Tent differed
from the norm, whereby women would be expected to self-refer
rather then be referred to the organisation.
Ritz 2000 graded 1.
The authors claim the groupswere similar butwith two exceptions:
women in the intervention group were significantly more likely
to have a lower histology ( p = 0.04) and to receive adjuvant
hormone therapy ( p = 0.03) then the women in the control group.
There is no evidence that this has been addressed in the analysis.
Levels of attrition were significant in both arms between baseline
and 24 months (Intervention group: baseline 95%, to 76% at
24months; Control group 76% at baseline to 52% at 24 months)
and data is presented up to and including12 months only. This
was explained as a reflection of decreased patient need between
12 and 24 months. Cost outcome data were complete for 141 (
intervention 74, control 64). A further 11 particiapants had some
data missing which was adjusted using the mean cost data for
simialr participants. The remaining 58 ( intervention 28, control
30) for whom cost data were incomplete were excluded from the
analysis. Missing cost data were attributed to different referral
patterns, changes in the participants’ insurance and transfer to a
different setting.
2. Supportive Care interventions during radiotherapy
Wengstrom 1999 was graded 2.
The authors reported that the randomisation procedure at baseline
failed to select groups with equal quality of life variables. They
acknowledge that this may be attributable to either a failure in
the randomisation procedure or a chance occurrence. The authors
report reasons for declining to participate in the study and the
withdrawal of 1 woman in the control group.
3. Nurse-led follow-up interventions
Koinberg 2004 graded 2.
The authors reported the study recruited 400 women over three
centres. They claim that in one centre the control and interven-
tion groups were too similar to include in the final analysis. This
therefore excluded 135 women from the final results. There are
no specific details reported about withdrawals or dropouts other
then death.
Some limitations in using the Jadad 1996 quality scoring scale to
assess quality of life research are noted. Papers which give details
of methods of randomisation and double blinding could score
artificially high despite the quality of these assessed components
being poor. It is noteworthy that other systematic reviewers have
identified the limitations of Jadad in assessing psychosocial and
quality of life research (Sola 2004).
Effects of interventions
The five studies in this review assessed the impact of the breast
care nurse on various aspects of quality of life, and indicators of
psychological, psychiatric and physical morbidity. Maguire 1980,
McArdle 1996 and Ritz 2000 measured anxiety and depression,
physical and social well-being and coping at different stages.
Wengstrom 1999 focused on coping, subjective distress and phys-
ical side effects of radiotherapy treatment and Koinberg 2004 con-
sidered well-being during follow-up. Many of the studies used
multiple instruments administered at numerous time points to
assess these outcomes. Some studies relied on patient reporting,
while others assessed the rate of referral between the BCN and
other health professionals. Many statistical methods to assess re-
sults were used by the studies. Reporting of results was generally
poor with some studies providing little in the way of quantative
results.
Therefore, this review presents a narrative synthesis of the main
results according to the different interventions identified. See Ad-
ditional Table 2 ’Study results’ for more information.
1. Psychosocial nursing interventions around diagnosis and
early treatment
Three studies with a total of 634 women assessed the effects of
a nursing intervention on psychological morbidity and quality of
life (Maguire 1980; McArdle 1996; Ritz 2000).
Maguire 1980 randomised 172 women post-mastectomy to usual
care (not explained) or counselling by a nurse specialist. Seventy
five patients were counselled by the nurse and 77 patients received
only the care normally provided by the surgical unit. Threemonths
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after mastectomy there was no difference between the counselled
group (29, 39%) and control group ( 33, 43%) in anxiety state,
depressive illness, sexual problems or a combination. Twelve to
eighteen months after mastectomy, 69 (92%) women in coun-
selled group were anxiety free as compared to 54 (70%) in the
control group. Depression was also less in the counselled group,
absent in 71 (95%) compared to 54 (70%) in the control group.
Consequently , 12-18 months after mastectomy there was much
less psychiatric morbidity in the counselled group (12%), com-
pared to 39% in the control group. The nursing intervention led
to recognition of psychiatric morbidity and prompted referral of
76% of those who required help, as opposed to 15% in the control
group.
The study only rated sexual problems in counselled patients and
48 controls who had reported a satisfactory sex life prior to surgery.
Sexual problems were identified in 15 of the control group and in
4 in the counselled group.
Recovery after surgery
Significantly more counselled (54, 72%) than control group (42,
55%) were satisfied with scar versus neutral or dissatisfied (chi-
squared+4.97, p>0.05); More of the control group (23, 33%) were
dissatisfied with their prosthesis than in the counselled group (11,
15%) (chi-squared = 6.66, p>0.02). More counselled (51, 68%)
than control group (40, 52%) had adapted to breast loss (chi-
squared = 4.07, p>0.05) although women in both counseled (8,
11%) and control (7, 9%) groups were unable to accept the loss
of a breast.
Differences in housework, social adjustment and return to work
were all improved in the counselled as opposed to control groups.
Nil versus some problems with housework (chi-squared+2.95,
p>0.05); for nil versus some problems in social adjustment (chi-
squared=5.01, p>0.05) and for return to work versus not (chi-
squared=4.59, p>0.05).
Counselled and control groups both had a small but important
minority (12%) who suffered from moderately severe or severe
swelling in a limb 12 - 18 months after surgery.
McArdle 1996 carried out a prospective RCT with 272 women.
The results indicate a reduction in psychological morbidity in the
group receiving care from the BCN. The data were summarised
using means and standard deviations despite an acknowledgment
of skewed data. Summary measure for each woman were taken
using the average value over the four assessments (postoperative
clinic visit and follow up at three, six and twelvemonths) and com-
pared measures using the Kruskal-Wallis test, with correction for
ties. This was followedwith pairwise multiple comparisons among
the four treatment groups using Mann-Whitney tests. These are
reported as unadjusted P values set at a significance level of 0.05.
A Bonferroni adjustment gave a significance level of 0.008 but
these adjusted levels are not presented. These results should be
viewed with caution as the authors acknowledged that the data
was skewed.
Ritz 2000 reported a RCT of 210 women randomised to receive
an intervention provided by an Advanced Practice Nurse (APN)
versus usual care on aspects of quality of life. This study indicated
that the intervention provided by an Advanced Practice Nurse
(APN) (American designation which meets criteria for BCN) was
beneficial in reducing levels of uncertainty of illness up to six
months following diagnosis but this was not the case at 12 months
where they were comparable. The beneficial effects of the APN
were greater for unmarried women than for married women (p
= 0.017). Differences in mood disturbance and well-being were
not statistically significant, apart from in the sub-group analysis,
which demonstrated a greater beneficial effect in the intervention
group for unmarried women.
The results of this study indicate that beneficial effects of interven-
tion by APNs are significant in the immediate six months follow-
ing diagnosis, but are not sustained beyond this. Women who are
unmarried appeared to benefit more fromAPN interventions than
married women. These findings may support the implementation
of APN support for some individuals during the initial adjustment
stages immediately following a diagnosis of breast cancer.
2. Supportive care interventions during radiotherapy
One study, (Wengstrom 1999) measured the effects of a nursing
intervention on subjective distress, side effects, coping and quality
of life of breast cancer patients receiving curative radiotherapy. In
this study,134 women from a total of 175 consecutive patients
agreed to be randomised to the intervention group (standard nurs-
ing care plus intensive nurse led intervention at weeks 1, 3, and
5 and three months) or control group (standard nursing care).
No significant differences were found between the two groups
comparing baseline data, however a significant difference in QOL
(p<0.05) indicated that women in the experimental group had a
poorer QOL than in the control group.
The intervention had a significant effect on perceived distress. The
women in the intervention group rated fewer distress reactions
than those in the control group (p<0.05). The intervention had
no measurable effect on global QOL or in perceived side effects.
Results from this study suggest that specific BCN interventions
can alleviate perceived distress during radiotherapy treatment but
may not improve coping skills, mood or overall quality of life. In
this study, the wide age range and different life stages of the women
may have impacted on perceived effects of the intervention.
3. Nurse-led follow-up interventions
One RCT (Koinberg 2004), compared routine follow up by a spe-
cialist oncology surgeon (including clinical examination) to fol-
low up by demand ( without clinical examination) managed by an
experienced nurse specialist on quality of life. In this study, 264
women were recruited from two hospitals. There were no statis-
tically significant differences between the groups for the main de-
mographic variables, satisfaction with care, access to medical care
and anxiety and depression. For anxiety and depression reported
problems varied between 4.4% and 11.6% for anxiety and 0.8%
and 5.2% for depression. Satisfaction in both group was ranked
highly over the follow-up period (93%-100%), suggesting that the
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women found each model acceptable.
Access to medical care
There were 21% more primary contacts in the specialist group.
In the nursing group there was a higher rate of mammaographies
but a similar rate of other imaging and laboratory tests.
The women’s experiences of accessibility and phone service use,
showed there were no statistically significant differences between
the groups.
4. Cost data
This review was also interested in cost data however only one of
the five included studies provided any information relating to cost
(Ritz 2000). In this study cost data were collected from hospital
and the clinic billing system for two years following the date of
diagnosis for each woman. The study was unable to collect some
costs such as anesthesiologists, emergency room physicians and
radiation oncologists but collected data on the length of hospitali-
sation and number of visits to a healthcare provider. Full cost data
were available for 141 women. Missing cost data for 11 women
were imputed using the mean cost data for similar women. The
remaining 58 women for whom cost data were incomplete (28 in
intervention group; 30 in control) were excluded from the anal-
ysis. The results indicated that the interventions by the APN did
not decrease cost of care but also identified fixed costs associated
with clinic appointments, treatments and hospital admissions that
the APN could not influence.
D I S C U S S I O N
This review of the effectiveness of individual interventions car-
ried out by BCNs on quality of life outcomes for women with a
diagnosis of breast cancer identified five RCTs for inclusion. No
quantitative analysis could be done due to heterogeneity among
interventions employed and the large numbers of, and diversity
of outcome measurements used, the variation in stages of breast
cancer among the participants and the variations in the meth-
ods of reporting statistical findings within studies. All studies in-
cluded participants with a wide age range and stage of disease. The
inclusion criteria, particularly in Koinberg 2004, Maguire 1980
and Wengstrom 1999, did not differentiate between the different
needs of age groups and life stages. This added to the difficulties
in combining data. Only one study (Ritz 2000) considered costs
and it was not possible to attribute cost reduction to nursing in-
terventions.
There is therefore limited evidence from RCTs to support some
of the BCN interventions at this time. The findings of this review
do however, lead us to the following discussion.
In categorising the studies according to the disease trajectory, it
became clear that there were limited assessments of BCN inter-
ventions beyond the diagnosis and treatment phase. The work by
Maguire 1980 initially set the precedent for the introduction of
BCNs in the United Kingdom. Since this time, there have been
few international trials building on this early work, althoughmany
countries now utilise BCNs. This review identified four RCTs in
addition to Maguire’s work which met the criteria. All of these
recognised the difficulties nurses experience in conducting RCTs
within practice. We also identified (but excluded) a number of
studies which assessed supportive interventions provided by a psy-
chologist. This indicates some blurring and overlapping of the
roles for these two disciplines.
We recognised that restricting the review to RCTs limits the possi-
bility of assessing the evidence relating to the effectiveness of BCN
interventions. The nature of the work, provided within a multi-
disciplinary team, serves to complement the work of the team as a
whole rather than highlighting the impact of the BCN alone. This
was clear in the study by Koinberg 2004, where the women were
equally satisfied with the care by the doctor and the nurse. BCNs
remain an integrated and respected part of the multidisciplinary
team.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
• The studies of interventions carried out by BCNs indicate
that they may provide some benefit to women with breast cancer,
particularly in the identification of anxiety and depression.
BCNs should ensure all aspects of quality of life are regularly
assessed as part of routine care.
• The findings suggest that the interventions had a short-
term, rather than a long-term benefit for women. BCNs may
need to provide focused interventions that reflect different stages
of a woman’s disease and treatment pathway, to provide
maximum supportive care.
• Supportive care interventions are not exclusively delivered
by BCNs. The provision of education and training should reflect
their work within multi-professional teams.
Implications for research
• A wide range of research is still required in this field,
encompassing both BCN specific outcomes and their
contribution to multi-professional working.
• In the future, RCTs with clearly identified outcomes and a
multi-centred approach are needed to ensure women receive the
optimum care from BCN interventions. This should include
cost analysis.
9Specialist breast care nurses for supportive care of women with breast cancer (Review)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
• We did not find the studies in this area to be of a high
overall quality and it is essential that in the future this is
addressed to ensure questions are answered in a rigorous and
valid manner.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Koinberg 2004
Methods RCT
Multicentre, Sweden
Data from 2 hospitals only included
Participants This trial included 264 patients with breast cancer
1. Specialist Nurse Group n =133.
2. Physician Group - routine follow up (control) n=131
Sex: 264 (100% female).
Mean Age: PG: 58.8; NG:60.0 (range <40-79).
Clinical Stage: 1 or 2.
Inclusion criteria: Newly diagnosed with breast cancer as either p-TNM Stage 1 or stage 11 in accordance
with the UICC classification.
Not participating in a clinical study which required a specific follow-up programme.
Able to give informed consent.
Interventions Specialist nurse intervention with check-ups on demand.
A nurse with specialist experience in breast cancer met patients approximately 3months following surgery.
Women received information about recognising recurrence, aspects of self-care and time to talk about
psychosocial aspects. Women advised to contact the nurse if symptoms arose which were perceived as due
to breast cancer.
Mammography carried out yearly arranged by the nurse.
Blood tests, chest x-ray or other imaging performed on clinical indication
CONTROL:
Routine follow-up visits to a physician.
Clinical examination/hospital visit 4 times per year following first 2 years, bi-annual for 5 years, yearly
after 5 years.
Mammography carried out yearly.
Blood tests, chest x-ray or other imaging performed on clinical indication
Outcomes Aspects of quality of life measured by:
1)Hospital Anxiety and Depression (HAD) Scale
2)Medical record review
3)Satisfaction and accessibility (SaaC) scale
The HAD and the SaaC were sent to the patient’s home 6 months post randomisation. The first data were
collected 6 months after randomisation and 6 monthly thereafter over a 3-year period. A 7th assessment
was done at 5 years.
Medical records were reviewed in the 5th year. This included number and type of medical consultation
and diagnostic procedures
Notes
Risk of bias
Item Authors’ judgement Description
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Koinberg 2004 (Continued)
Allocation concealment? Yes A - Adequate
Maguire 1980
Methods Controlled Trial
Study site not specified - presumed to be an acute hospital setting
Participants This trial included 172 patients post mastectomy
20 recruits withdrew.
1. Specialist Nurse Group n= 75.
2. Routine care by surgical unit (Control) n= 77
Sex: 152 (100%) Female
Mean Age: not specified.
Clinical condition: Breast cancer patients who had a modified radical mastectomy and full axillary clear-
ance.
Inclusion criteria:
Not specified and no details of how informed consent was obtained
Interventions INTERVENTION:
Nurse-led counselling service.
Woman seen by nurse within a few days of surgery and thereafter every 2 months at home.
Follow up for 12-18 months after mastectomy.
CONTROL:
Routine care from surgical unit.
Outcomes Psychiatic morbidity measured by:
1.Anxiety, depression and sexual problems (Present state examination).
2.Assessment of other stressful life events
3.Mood (Linear analogue scales 12-18 months post mastectomy).
4.Semi-structured interview shortly after surgery, 3, and 12-18 months following surgery to assess physical
and social recovery in three areas:
swelling, pain and disability.
reaction to scar, breast loss and prosthesis.
house work, social adjustment, return to work.
Notes This data is taken from bothMaguire 1980 and 1983. Maguire 1983 is referenced in additional references
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear D - Not used
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McArdle 1996
Methods Prospective RCT:
Participants This trial included 272 patients with breast cancer randomised prior to surgery;
1. Routine care n=67 (median age 59);
2. Routine care plus Breast Care Nurse n=70 (BCN) (median age 55);
3. Routine care plus support from voluntary organisation (Tak Tent (TT) n=66 (median age 56);
4. Routine care plus support from the voluntary organisation and the BCN n=69 (median age 57)
122 had mastectomy.
144 had lumpectomy.
Adjuvant treatment.
124 - no adjuvant treatment or tamoxifen alone.
103 radiotherapy.
41- chemotherapy.
Mean Age: SMC: 55.3; APN: 55.7 ( range < 30-85yrs).
Clinical condition:
Breast cancer.
Inclusion criteria:
Patients under 70 years.
Undergoing breast cancer surgery.
Ability to attend follow up clinic.
Exclusion criteria:
Non-English speaking.
Deafness.
Low intellect - no criteria for assessment given.
Psychiatric illness/cognitive impairment.
Interventions Four groups:
a) Routine support fromward staff and information booklet (Understanding cancer of the breast: BACUP)
b) Routine care as per group A plus support from breast care nurse (BCN)
c) Routine care as per group A plus support from a voluntary organisation (Tak Tent)
d) Routine care as per group A plus support from BCN and the voluntary organisation
Outcomes Psychological morbidity measured using:
1.28-tem general health questionnaire.
2. Hospital Anxiety and Depression (HAD) Scale.
Data collection using validated assessment tools at baseline, 3, 6,12 months after surgery
Notes The authors report the median age of women, not the mean
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Ritz 2000
Methods RCT:
Participants This trial included 210 patients with breast cancer
1. Advanced Practice Nurse (APN) Group n=106
2. Standard medical care (SMC) Group n=104
Sex: 210 (100%) Female.
Mean Age: SMC: 55.3; APN: 55.7 ( range <30-85yrs).
Clinical condition:
Intervention group more likely to have lower histology (p = 0.04) and receive adjuvant hormone therapy
(p = 0.03) than women in the control group
Inclusion criteria:
Women aged 21 years or older.
Able to read and write in English.
Able to give informed consent.
Consent gained within two weeks of diagnosis.
Physician referral from within the care system.
Exclusion criteria:
History of cancer.
Co-morbidities that limited functional ability.
Severe psychiatric illness.
Interventions INTERVENTION:
SMC plus APN care provided during clinic, hospital, telephone and homecare visits.
Interventions included assessment, diagnosis, outcome identification, planning, coordination, symptom
management, health education, consultation, research based on ONS standards of advanced practice
CONTROL:
SMC described as routine medical care but this is not defined
Outcomes Aspects of quality of life measured by:
1. Mishel Uncertainty in Illness Scale (MUIS).
2. Profile of Mood States (POMS).
3. Functional Assessment of Cancer Therapy (FACT-B).
Data collected for 2 years at baseline, 1, 3, 6, 12, 18 and 24 months using validated tools
Cost data:
Collected from hospital & clinic billing system for 2 years following the date of diagnosis for each woman.
Unable to collect some costs such as anesthesiologists, emergency room physicians and radiation oncolo-
gists but collected data on the length of hospitalisation and number of visits to a healthcare provider.
Full cost data were available for 141 women.
Missing cost data for 11 women were imputed using the mean cost data for similar women.
The remaining 58 women for whom cost data were incomplete (28 in intervention group; 30 in control)
were excluded from the analysis
Notes The authors refer to the mean age of the women
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Wengstrom 1999
Methods RCT single centre hospital in Sweden.
Participants This trial included 134 women with breast cancer
Age group 37-83 mean age 61 years.
1. Nurse-led intervention - 30 minutes once a week at week 1 baseline then 3, 5 and follow up at 2 weeks
and again at 3 months n=67
2. Standard nursing care n=67
No significant differences found at baseline between the two groups using student’s t-test to compare
distress and side effects
A diagnosis of breast cancer including chest wall and lymph nodes receiving radiotherapy treatment for
cure.
No restriction based on stage but had to speak and understand English
Interventions INTERVENTION:
Nurse-led intervention as a complement to standard nursing care in the radiotherapy department.
First intervention at baseline, emphasis on oral and written cognitive information about simulation and
treatment routines - this session lasted 45 minutes as opposed to those later which lasted 30 minutes
CONTROL:
Standard nursing care
Outcomes Subjective distress, side effects and quality of life measured by:
1. Instruments Impact of Event Scale (IES scale) a self reported questionnaire containing15 items including
7 items under the heading intrusion and 8 items of avoidance.
2. Oncology Treatment Toxicity Assessment Tool (OTTAT) a self reported instrument containing 37
items to assess cancer related symptoms including side effects of treatments. Every item is rated on a 5
point scale from none to intolerable.
3. Cancer Rehabilitation Evaluation System (CARES-sf ) was used to measure Quality of Life and is a
shortened version of a standardised and comprehensive rehabilitation and QoL questionnaire used for
cancer patients. This consisted of 59 items and patients were asked to complete a minimum of 37 to a max
of 57 items. The ratings change on this from a 5-point scale from 0 does not apply to 4 applies very much.
This item is multidimensional with reliability, validity and internal consistency previously documented
Notes This is the primary study
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Allen 2002 The study did not meet inclusion criteria
Ambler 1999 The study did not meet the inclusion criteria
Bordeleau 2003 The study did not include disaggregated data for nursing
Brown 2002 The study did not meet the inclusion criteria
Cimprich 1993 Outcomes did not meet inclusion criteria
Cleeland 1996 Outcomes did not meet inclusion criteria
Giese-Davis 2002 The study did not meet the inclusion criteria
Goodwin 2003 The study did not include disaggregated data for nursing
Helgeson 1999 The study did not include disaggregated data for nursing
Hughes 2000 The study did not meet the inclusion criteria
Ironson 2002 Insufficient data available
Kolcaba 1999 Outcomes did not meet inclusion criteria
Larsson 1992 The study did not meet the inclusion criteria
Lev 2001 The study did not include disaggregated data for nursing
Maguire 1985 The study did not meet inclusion criteria
Mock 1997 Outcomes did not meet inclusion criteria
Motzer 1997 Outcomes did not meet inclusion criteria
Rolnick 1999 The study did not meet the inclusion criteria
Samarel 2002 The study did not include disaggregated data for nursing
Sameral 1998 The study did not meet the inclusion criteria
Sandgren 2000 The study did not meet inclusion criteria
Sandgren 2003 The study did not meet inclusion criteria
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(Continued)
Targ 2002 The study did not meet inclusion criteria
Vos 2004 The study did not meet the inclusion criteria
Williams 2004 The study outcomes did not meet inclusion criteria
Wyatt 2004 No nursing intervention
Characteristics of ongoing studies [ordered by study ID]
Arving 2006
Trial name or title Satisfaction, utilisation and perceived benefit of individual psychosocial support for breast cancer patients
Methods
Participants 179 women with breast cancer
Interventions Standard care, individual psychosocial support from a trained oncology nurse, individual support by a psy-
chologist
Outcomes The patient satisfaction questionnaire.
Hospital Anxiety and Depression Scale.
The Impact of Event Scale.
Starting date December 1997
Contact information cecilia.arving@pubcare.uu.se
Notes The quality of life data has still to be published. The authors were contacted and had anticipated its availability
in December 2006 but we do not have the data to present
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D A T A A N D A N A L Y S E S
This review has no analyses.
A D D I T I O N A L T A B L E S
Table 1. Quality assessment
Study Quality Assessment
Maguire 1980 Jadad score:
Randomisation identified: 1
Method described: 1
Blinding: 0
Method of blinding 0
Withdrawals/dropouts 1
Deduct 1 if randomisation
inappropriate -1
Deduct 1 if blinding
inappropriate 0
Overall quality assessment: 2/5
McArdle 1996 Jadad Score:
Randomisation identified: 1
Method described: 0
Described as double blind
Method of double blinding
appropriate: 0
Withdrawals/dropouts: 1
Deduct 1 if randomisation inappropriate: -1
Deduct one if blinding inappropriate: 0
Overall quality assessment: 1 (study described as randomised)
Koinberg 2004 Jadad Score:
Randomisation described: 1
Method described: 1
Double blinding: 0
Method of double blinding: 0
Withdrawals/dropouts: 0
Deduct 1 if randomisation
inappropriate: 0
Deduct one if blinding
inappropriate: 0
Overall quality assessment: 2/5
Ritz 2004 Jadad Score
Randomisation described: 1
Method described: 0
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Table 1. Quality assessment (Continued)
Described as double blind: 0
Method of double blinding
appropriate: 0
Withdrawals/dropouts: 1
Deduct 1 if randomisation inappropriate: -1
Deduct one if blinding inappropriate: 0
Overall quality assessment: 1
Wengstrom Jadad Score:
Randomisation described: 1
Method described: 1
Double blind: 0
Method of double blinding
appropriate: 0
Withdrawals/dropouts: 1
Deduct 1 if randomisation inappropriate: -1
Deduct 1 if blinding inappropriate: 0
Overall quality assessment: 2/5
Table 2. Study results
Study Outcome measure Intervention group Control Results
Koinberg 2004 Aspects of quality of life
measured by:
1)Hospital Anxiety and
Depression (HAD) Scale
2)Medical record review
(MRR)
3)Satisfaction and accessi-
bility (SaaC) scale
Specialist Nurse Group n=
133.
Physician Group (routine
follow up) n=131
1. HAD
A relative risk (RR) with
a 95% confidence interval
for the nurse group (NG)
over the physician group
(PG) was used as a refer-
ence. There were no sta-
tistically significant differ-
ences beteen the groups
for either anxiety or de-
pression.
Anxiety
6mths - RR 1.8 (95% CI
0.7-4.8)
18mths - RR 1.2 (95% CI
0.4-3.1)
24mths- RR 2.3 (95% CI
0.8-6.9
60mths- RR 1.8 (95% CI
0.6-5.1)
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Table 2. Study results (Continued)
Depression
6mths - RR 1.0 (95% CI
0.6-16.4)
18mths - RR 0.5 (95% CI
0.0 -5.8)
24mths- RR 1.0 (95% CI
0.1-7.2)
60mths- RR 1.7 (95% CI
0.4-7.2)
2. SaaC
Satisfaction was high over
the follow-up period.
6mths - RR 0.6 (95% CI
0.1-3.9)
18mths - RR 1.0 (95% CI
1.0 -1.0)
24mths- RR 0.3 (95% CI
0.0-1.2)
60mths- RR 0.1 (95% CI
0.0-0.9)
3. Medical Safety was con-
sidered as part of the
MMR
The time to recurrence or
death was analysed using
the Kaplan Meier tech-
nique with 95% confi-
dence limits: time to loco-
regional recurrence 3% (
-2,8)ª, time to distant
metastases 0.6% (-6,5)ª,
time to any first breast can-
cer recurrence 2% (-5,9)ª,
time to death -0.3% (-10,
9)³ power in this analyses
was low
Maguire 1980 Psychiatric morbidity
measured by:
1.Anxiety, depression and
sexual problems (Present
state examination).
2.Assessment of other
stressful life events
3.Mood (Linear analogue
scales 12-18 months post
Specialist Nurse Group n
=75.
Routine care by surgical
unit n=77.
1. Anxiety, depression and
sexual problems.
No difference between
counselled group and con-
trol group at 3 months.
Comparisons between
counselling and control
groups at 12-18 months
for anxiety states (p<0.01)
, depressive illness (p< 0.
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Table 2. Study results (Continued)
mastectomy).
4.Semi-struc-
tured interview shortly af-
ter surgery, 3, and 12-18
months following surgery
to assess physical and so-
cial recovery in three areas:
swelling, pain and disabil-
ity.
reaction to scar, breast loss
and prosthesis.
house work, social adjust-
ment, return to work.
001) and sexual problems
(p<0.02)
2. Recovery after Surgery
More counselled women
than control were satis-
fied with scar (p>0.05)
, had adapted to breast
loss (p>0.05), social ad-
justment (p>0.05)
McArdle 1996 Psychological morbidity
measured by:
1. 28-tem general health
questionnaire.
2. Hospital Anxiety and
Depression (HAD) Scale.
a) Routine support from
ward staff and informa-
tion booklet (Understand-
ing cancer of the breast:
BACUP) plus Breast Care
Nurse (BCN) n=70
b) Routine sup-
port from ward staff and
information booklet (Un-
derstanding cancer of the
breast: BACUP) plus sup-
port from BCN and the
voluntary organisation n=
69
a) Routine support from
ward staff and informa-
tion booklet (Understand-
ing cancer of the breast:
BACUP) n=67
b) Routine sup-
port from ward staff and
information booklet (Un-
derstanding cancer of the
breast: BACUP) plus sup-
port from a voluntary or-
ganisation (TT) n=66
1. General Health Ques-
tionnaire and 2. HAD
Psychological
morbidity fell over the 12
month period. Scores were
consistently lower in pa-
tients supported byBCNs.
The unadjusted p values
were 0.015 (28 general
health questionnaire), 0.
027 (anxiety and insom-
nia), 0.072 (severe de-
pression), 0.053 (somatic
symptoms), 0.031 ( so-
cial dysfunction), 0.093 (
HAD - anxiety) and 0.003
(HAD - depression).
No other statistical results
provided
Ritz 2000 Aspects of quality of life
measured by:
1.Mishel Uncertainty in
Illness Scale (MUIS).
2. Profile of Mood States
(POMS).
3. Functional Assessment
of Cancer Therapy
(FACT-B).
Cost data:
Collected from hospital &
clinic billing system for 2
years following the date of
Advanced Practice Nurse
(APN) Group n=106.
Standard medical care
(SMC) Group n=104
1. Uncertainty
Uncertainty was signifi-
cantly reduced in inter-
vention group (p=0.043)
at baseline, 1 month (p=0.
001), 3 months (p=0.026)
and 6 months (p=0.011)
but not at 12 months (p=
0.589).
No significant differences
between groups in levels
of mood (p=0.953) how-
ever, unmarried women
showed adecrease inmood
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Table 2. Study results (Continued)
diagnosis for eachwoman.
Unable to collect some
costs such as anesthesi-
ologists, emergency room
physicians and radiation
oncologists but collected
data on the length of hos-
pitalisation and number
of visits to a healthcare
provider.
Full cost data were avail-
able for 141 women.
Missing cost data for 11
women were imputed us-
ing the mean cost data for
similar women.
The remaining 58 women
for whom cost data were
incomplete (28 in inter-
vention group; 30 in con-
trol) were excluded from
the analysis
disturbance in the inter-
vention group at 1 month
(p=0.011) and 3 month
(p=0.043). Additionally,
women with no family
history of breast cancer
showed adecrease inmood
disturbance at 1 month
(p=0.002), 3 month (p=0.
010) and 6 month (p=0.
004).
There was no statisti-
cal difference between in-
tervention and control
groups for well-being but
unmarried women in in-
tervention group reported
higher levels of well-being
at 1 month (p=0.036).
Cost data:
No significant difference
in costs between groups
existed. The costs of the
APN intervention aver-
aged at $629 per patient.
Data collection relating to
costs appeared to be prob-
lematic with full cost data
only available for 141.
The study imputed miss-
ing cost data for 11 par-
ticipants using the mean
cost data for similar par-
ticipants. The study ex-
cluded the remaining 58
participants forwhomcost
data were incomplete (28
in intervention group; 30
in control) from the anal-
ysis
Wengstrom 1999 Subjective distress, side ef-
fects and quality of life
measured by:
1. Instruments Impact of
Event Scale (IES scale) a
Nurse led intervention n=
67
Standard nursing care n=
67
1.Distress
Patients in the interven-
tion group rated fewer dis-
tress reactions than the
control (p<0.05) - CI not
provided
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Table 2. Study results (Continued)
self reported questionnaire
containing 15 items in-
cluding 7 items under the
heading intrusion and 8
items of avoidance.
2. Oncology Treatment
Toxicity Assessment Tool
(OTTAT) a self reported
instrument containing 37
items to assess cancer re-
lated symptoms including
side effects of treatments.
Every item is rated on a 5
point scale from none to
intolerable.
Cancer Rehabilitation
Evaluation System
3. (CARES-sf ) was used
to measure Quality of Life
and is a shortened ver-
sion of a standardised and
comprehensive rehabilita-
tion and QoL question-
naire used for cancer pa-
tients.
This consisted of 59 items
and patients were asked to
complete a minimum of
37 to a max of 57 items.
The ratings change on this
from a 5-point scale from
0 does not apply to 4 ap-
plies very much. This item
is multidimensional with
reliability, validity and in-
ternal consistency previ-
ously documented
2. Side effects
The Oncology Treatment
Toxicity Assessment Tool
showed no significant ef-
fect between the two
groups in perceived side
effects - p value and CI not
provided
3. Quality of life
While
the EG scored higher at
baseline on theCARES - sf
global score, the interven-
tion had no measurable ef-
fect on global QOL - p
value and CI not provided
The authors carried out a
multiple regression analy-
sis to control for differ-
ences in treatment dose
and type of surgery, how-
ever the difference in treat-
ment dose could not ex-
plain why the intervention
and control groups were
similar in perceived side
effects
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A P P E N D I C E S
Appendix 1. Search strategy for Medline (OVID 1966- September 2005)
1 exp breast neoplasms/ (125717)
2 exp “Neoplasms, Ductal, Lobular, and Medullary”/ (14720)
3 exp Fibrocystic Breast Disease/ (2449)
4 or/1-3 (130325)
5 exp breast/ (19852)
6 breast.tw. (148593)
7 5 or 6 (154239)
8 (breast adj milk).ti,ab,sh. (5020)
9 (breast adj tender$).ti,ab,sh. (258)
10 or/8-9 (5278)
11 7 not 10 (148961)
12 exp neoplasms/ (1619750)
13 11 and 12 (117201)
14 exp lymphedema/ (5798)
15 14 and 11 (507)
16 (breast adj25 neoplasm$).ti,ab,sh. (4491)
17 (breast adj25 cancer$).ti,ab,sh. (93726)
18 (breast adj25 tumour$).ti,ab,sh. (8002)
19 (breast adj25 tumor$).ti,ab,sh. (30301)
20 (breast adj25 carcinoma$).ti,ab,sh. (30103)
21 (breast adj25 adenocarcinoma$).ti,ab,sh. (3098)
22 (breast adj25 sarcoma$).ti,ab,sh. (1513)
23 (breast adj50 dcis).ti,ab,sh. (1119)
24 (breast adj25 ductal).ti,ab,sh. (4609)
25 (breast adj25 infiltrating).ti,ab,sh. (1628)
26 (breast adj25 intraductal).ti,ab,sh. (1020)
27 (breast adj25 lobular).ti,ab,sh. (1804)
28 (breast adj25 medullary).ti,ab,sh. (393)
29 or/16-28 (116361)
30 4 or 13 or 15 or 29 (153912)
31 exp mastectomy/ (14410)
32 30 or 31 (155831)
33 exp “ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES AND EQUIPMENT”/ (8790014)
34 33 and 11 (120040)
35 34 or 32 (171896)
36 exp mammary neoplasms/ (14579)
37 (mammary adj25 neoplasm$).ti,ab,sh. (628)
38 (mammary adj25 cancer$).ti,ab,sh. (6214)
39 (mammary adj25 tumour$).ti,ab,sh. (2447)
40 (mammary adj25 tumor$).ti,ab,sh. (13352)
41 (mammary adj25 carcinoma$).ti,ab,sh. (7574)
42 (mammary adj25 adenocarcinoma$).ti,ab,sh. (2612)
43 (mammary adj25 sarcoma$).ti,ab,sh. (497)
44 (mammary adj50 dcis).ti,ab,sh. (88)
45 (mammary adj25 ductal).ti,ab,sh. (1145)
46 (mammary adj25 infiltrating$).ti,ab,sh. (253)
47 (mammary adj25 intraductal$).ti,ab,sh. (224)
48 (mammary adj25 lobular).ti,ab,sh. (282)
49 (mammary adj25 medullary).ti,ab,sh. (60)
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50 or/36-49 (27625)
51 35 or 50 (188466)
52 exp breast self examination/ (736)
53 (breast adj25 self$).ti,ab,sh. (2579)
54 (breast adj25 screen$).ti,ab,sh. (8737)
55 exp mammography/ (15692)
56 or/51-55 (190550)
57 mammograph$.tw. (12822)
58 57 and 11 (9452)
59 56 or 58 (190559)
60 randomized controlled trial.pt. (206425)
61 controlled clinical trial.pt. (69387)
62 randomized controlled trials.sh. (39195)
63 random allocation.sh. (53837)
64 double-blind method.sh. (83248)
65 single blind method.sh. (9290)
66 or/60-65 (351133)
67 clinical trial.pt. (415676)
68 exp clinical trials/ (169873)
69 (clin$ adj25 trial$).ti,ab. (114055)
70 ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).ti,ab. (82599)
71 placebos.sh. (24028)
72 placebo$.ti,ab. (90784)
73 random$.ti,ab. (318857)
74 research design.sh. (41712)
75 or/67-74 (746854)
76 66 or 75 (767881)
77 59 and 76 (21791)
78 animals.mp. not human.sh. [mp=title, original title, abstract, name of substance word, subject heading word] (3821636)
79 77 not 78 (19682)
80 exp breast neoplasms/nu (791)
81 exp nurse clinicians/ (5322)
82 exp nurse’s role/ (11077)
83 exp oncologic nursing/ (3794)
84 exp nurse practitioner/ (10513)
85 (cancer adj25 nurs$).ti,ab,sh. (5221)
86 (breast adj25 nurs$).ti,ab,sh. (2025)
87 (support$ adj25 (care or caring)).ti,ab,sh. (29900)
88 or/80-87 (61658)
89 exp palliative care/ (23943)
90 palliat$.ti,ab,sh. (36729)
91 or/89-90 (36729)
92 79 and 88 (392)
93 79 and 91 (452)
94 from 93 keep 1-452 (452)
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Appendix 2. Search strategy for CINAHL (OVID 1982-September 2005)
1 exp breast neoplasms/ (11134)
2 exp “Neoplasms, Ductal, Lobular, and Medullary”/ (9)
3 exp Fibrocystic Breast Disease/ (94)
4 or/1-3 (11188)
5 exp breast/ (677)
6 breast.tw. (12267)
7 5 or 6 (12548)
8 (breast adj milk).ti,ab,sh. (598)
9 (breast adj tender$).ti,ab,sh. (20)
10 or/8-9 (618)
11 7 not 10 (11930)
12 exp neoplasms/ (47708)
13 11 and 12 (8522)
14 exp lymphedema/ (487)
15 14 and 11 (132)
16 (breast adj25 neoplasm$).ti,ab,sh. (32)
17 (breast adj25 cancer$).ti,ab,sh. (8366)
18 (breast adj25 tumour$).ti,ab,sh. (91)
19 (breast adj25 tumor$).ti,ab,sh. (431)
20 (breast adj25 carcinoma$).ti,ab,sh. (269)
21 (breast adj25 adenocarcinoma$).ti,ab,sh. (13)
22 (breast adj25 sarcoma$).ti,ab,sh. (16)
23 (breast adj50 dcis).ti,ab,sh. (20)
24 (breast adj25 ductal).ti,ab,sh. (92)
25 (breast adj25 infiltrating).ti,ab,sh. (18)
26 (breast adj25 intraductal).ti,ab,sh. (17)
27 (breast adj25 lobular).ti,ab,sh. (27)
28 (breast adj25 medullary).ti,ab,sh. (3)
29 or/16-28 (8544)
30 4 or 13 or 15 or 29 (12417)
31 exp mastectomy/ (1061)
32 30 or 31 (12689)
33 exp “ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES AND EQUIPMENT”/ (0)
34 33 and 11 (0)
35 34 or 32 (12689)
36 exp mammary neoplasms/ (0)
37 (mammary adj25 neoplasm$).ti,ab,sh. (1)
38 (mammary adj25 cancer$).ti,ab,sh. (39)
39 (mammary adj25 tumour$).ti,ab,sh. (4)
40 (mammary adj25 tumor$).ti,ab,sh. (22)
41 (mammary adj25 carcinoma$).ti,ab,sh. (11)
42 (mammary adj25 adenocarcinoma$).ti,ab,sh. (3)
43 (mammary adj25 sarcoma$).ti,ab,sh. (1)
44 (mammary adj50 dcis).ti,ab,sh. (0)
45 (mammary adj25 ductal).ti,ab,sh. (4)
46 (mammary adj25 infiltrating$).ti,ab,sh. (1)
47 (mammary adj25 intraductal$).ti,ab,sh. (0)
48 (mammary adj25 lobular).ti,ab,sh. (0)
49 (mammary adj25 medullary).ti,ab,sh. (0)
50 or/36-49 (55)
51 35 or 50 (12702)
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52 exp breast self examination/ (808)
53 (breast adj25 self$).ti,ab,sh. (1043)
54 (breast adj25 screen$).ti,ab,sh. (1453)
55 exp mammography/ (2407)
56 or/51-55 (13723)
57 mammograph$.tw. (1545)
58 57 and 11 (911)
59 56 or 58 (13725)
60 randomized controlled trial.pt. (0)
61 controlled clinical trial.pt. (0)
62 randomized controlled trials.sh. (0)
63 random allocation.sh. (0)
64 double-blind method.sh. (0)
65 single blind method.sh. (0)
66 or/60-65 (0)
67 clinical trial.pt. (14956)
68 exp clinical trials/ (32936)
69 (clin$ adj25 trial$).ti,ab. (10482)
70 ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).ti,ab. (4822)
71 placebos.sh. (2824)
72 placebo$.ti,ab. (6470)
73 random$.ti,ab. (32132)
74 research design.sh. (0)
75 or/67-74 (54571)
76 66 or 75 (54571)
77 59 and 76 (1610)
78 animals.mp. not human.sh. [mp=title, subject heading word, abstract, instrumentation] (2134)
79 77 not 78 (1607)
80 exp breast neoplasms/nu (211)
81 exp nurse clinicians/ (2880)
82 exp nurse’s role/ (0)
83 exp oncologic nursing/ (6052)
84 exp nurse practitioner/ (7486)
85 (cancer adj25 nurs$).ti,ab,sh. (4485)
86 (breast adj25 nurs$).ti,ab,sh. (1209)
87 (support$ adj25 (care or caring)).ti,ab,sh. (13839)
88 or/80-87 (31752)
89 exp palliative care/ (4935)
90 palliat$.ti,ab,sh. (6556)
91 or/89-90 (6556)
92 79 and 88 (173)
93 79 and 91 (26)
94 from 93 keep 1-26 (26)
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Appendix 3. Search strategy EMBASE (OVID 1980-September 2005)
1 exp breast cancer/ (110263)
2 exp neoplasms/ and medullary.mp. (5731)
3 exp fibrocystic disease of breast/ (538)
4 or/1-3 (115736)
5 exp breast/ (36787)
6 breast.tw. (122844)
7 5 or 6 (139515)
8 (breast adj milk).ti,ab,sh. (4860)
9 (breast adj tender$).ti,ab,sh. (260)
10 or/8-9 (5120)
11 7 not 10 (134395)
12 exp neoplasms/ (1162318)
13 11 and 12 (103921)
14 exp lymphedema/ (3132)
15 14 and 11 (527)
16 (breast adj25 neoplasm$).ti,ab,sh. (1792)
17 (breast adj25 cancer$).ti,ab,sh. (83412)
18 (breast adj25 tumour$).ti,ab,sh. (7529)
19 (breast adj25 tumor$).ti,ab,sh. (26684)
20 (breast adj25 carcinoma$).ti,ab,sh. (24751)
21 (breast adj25 adenocarcinoma$).ti,ab,sh. (2538)
22 (breast adj25 sarcoma$).ti,ab,sh. (1306)
23 (breast adj25 dcis).ti,ab,sh. (949)
24 (breast adj25 ductal).ti,ab,sh. (4222)
25 (breast adj25 infiltrating).ti,ab,sh. (1467)
26 (breast adj25 intraductal).ti,ab,sh. (859)
27 (breast adj25 lobular).ti,ab,sh. (1556)
28 (breast adj25 medullary).ti,ab,sh. (357)
29 or/16-28 (100438)
30 4 or 13 or 15 or 29 (137025)
31 exp mastectomy/ (10071)
32 30 or 31 (138187)
33 exp mammary neoplasms/ (111055)
34 (mammary adj25 neoplasm$).ti,ab,sh. (418)
35 (mammary adj25 cancer$).ti,ab,sh. (5140)
36 (mammary adj25 tumour$).ti,ab,sh. (1787)
37 (mammary adj25 tumor$).ti,ab,sh. (10400)
38 (mammary adj25 carcinoma$).ti,ab,sh. (6222)
39 (mammary adj25 adenocarcinoma$).ti,ab,sh. (2062)
40 (mammary adj25 sarcoma$).ti,ab,sh. (328)
41 (mammary adj25 dcis).ti,ab,sh. (62)
42 (mammary adj25 ductal).ti,ab,sh. (939)
43 (mammary adj25 infiltrating).ti,ab,sh. (211)
44 (mammary adj25 inrtaductal).ti,ab,sh. (0)
45 (mammary adj25 lobular).ti,ab,sh. (226)
46 (mammary adj25 medullary).ti,ab,sh. (43)
47 or/33-46 (126999)
48 32 or 47 (245251)
49 exp breast self examination/ (17759)
50 (breast adj25 self$).ti,ab,sh. (1979)
51 (breast adj25 screen$).ti,ab,sh. (7406)
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52 exp mammography/ (15038)
53 or/48-52 (249496)
54 mammograph$.tw. (10617)
55 54 and 11 (8351)
56 53 or 55 (249567)
57 exp clinical trial/ (360000)
58 comparative study/ (66902)
59 drug comparison/ (81244)
60 major clinical study/ (992273)
61 randomization/ (16175)
62 crossover procedure/ (16647)
63 double blind procedure/ (57117)
64 single blind procedure/ (5507)
65 placebo/ (80452)
66 prospective study/ (49825)
67 ((clinical or controlled or comparative or placebo or prospective or randomi#ed) adj3 (trial or study)).ti,ab. (276562)
68 (random$ adj7 (allocat$ or allot$ or assign$ or basis$ or divid$ or order$)).ti,ab. (58270)
69 ((singl$ or doubl$ or trebl$ or tripl$) adj7 (blind$ or mask$)).ti,ab. (77858)
70 (cross?over$ or (cross adj1 over$)).ti,ab. (32543)
71 or/57-70 (1544853)
72 56 and 71 (54915)
73 limit 72 to human (52259)
74 exp nursing/ (11411)
75 exp nurse/ (11251)
76 exp nurse practitioner/ (1223)
77 or/74-76 (22708)
78 (cancer adj25 nurs$).ti,ab,sh. (2008)
79 (breast adj25 nurs$).ti,ab,sh. (1134)
80 (support$ adj25 (care or caring)).ti,ab,sh. (21107)
81 or/78-80 (23617)
82 77 or 81 (44401)
83 73 and 82 (585)
84 exp palliative therapy/ (15842)
85 exp hospice care/ (314)
86 or/84-85 (15950)
87 (palliat$ or hospice$).ti,ab. (21434)
88 86 or 87 (27318)
89 73 and 88 (745)
90 from 89 keep 1-200 (200)
91 from 89 keep 201-400 (200)
92 from 89 keep 401-600 (200)
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Appendix 4. 4 Search strategy PsycINFO (OVID 1967 to September 2005)
1 exp breast cancer/ (1010)
2 exp neoplasms/ and medullary.mp. (9)
3 (fibrocystic adj25 disease$).ti,ab,sh. (20)
4 or/1-3 (1039)
5 exp breast/ (403)
6 breast.ti,ab,sh. (5745)
7 5 or 6 (5745)
8 (breast adj milk).ti,ab,sh. (162)
9 (breast adj tender$).ti,ab,sh. (26)
10 or/8-9 (188)
11 7 not 10 (5557)
12 exp neoplasms/ (15300)
13 11 and 12 (3484)
14 lymphedema$.ti,ab,sh. (19)
15 14 and 11 (14)
16 (breast adj25 neoplasm$).ti,ab,sh. (39)
17 (breast adj25 cancer$).ti,ab,sh. (3907)
18 (breast adj25 tumour$).ti,ab,sh. (16)
19 (breast adj25 tumor$).ti,ab,sh. (104)
20 (breast adj25 carcinoma$).ti,ab,sh. (60)
21 (breast adj25 adenocarcinoma$).ti,ab,sh. (3)
22 (breast adj25 sarcoma$).ti,ab,sh. (3)
23 (breast adj25 dcis).ti,ab,sh. (5)
24 (breast adj25 ductal).ti,ab,sh. (10)
25 (breast adj25 infiltrating).ti,ab,sh. (1)
26 (breast adj25 intraductal).ti,ab,sh. (1)
27 (breast adj25 lobular).ti,ab,sh. (1)
28 (breast adj25 medullary).ti,ab,sh. (2)
29 or/16-28 (3955)
30 4 or 13 or 15 or 29 (4599)
31 exp mastectomy/ (308)
32 30 or 31 (4720)
33 exp mammary neoplasms/ (3183)
34 (mammary adj25 neoplasm$).ti,ab,sh. (0)
35 (mammary adj25 cancer$).ti,ab,sh. (16)
36 (mammary adj25 tumour$).ti,ab,sh. (0)
37 (mammary adj25 tumor$).ti,ab,sh. (26)
38 (mammary adj25 carcinoma$).ti,ab,sh. (12)
39 (mammary adj25 adenocarcinoma$).ti,ab,sh. (4)
40 (mammary adj25 sarcoma$).ti,ab,sh. (0)
41 (mammary adj25 dcis).ti,ab,sh. (0)
42 (mammary adj25 ductal).ti,ab,sh. (2)
43 (mammary adj25 infiltrating).ti,ab,sh. (0)
44 (mammary adj25 inrtaductal).ti,ab,sh. (0)
45 (mammary adj25 lobular).ti,ab,sh. (0)
46 (mammary adj25 medullary).ti,ab,sh. (0)
47 or/33-46 (3209)
48 32 or 47 (4841)
49 (breast adj25 (self adj examination$)).ti,ab,sh. (381)
50 (breast adj25 self$).ti,ab,sh. (902)
51 (breast adj25 screen$).ti,ab,sh. (691)
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52 exp mammography/ (481)
53 or/48-52 (5232)
54 mammograph$.tw. (681)
55 54 and 11 (447)
56 53 or 55 (5237)
57 exp clinical trials/ (1433)
58 exp empirical methods/ (15439)
59 (comparative adj stud$).ti,ab,sh. (6808)
60 (drug adj comparison$).ti,ab,sh. (16)
61 (major adj (clinical adj stud$)).ti,ab,sh. (5)
62 placebo/ (1750)
63 prospective studies/ (281)
64 ((clinical or controlled or comparative or placebo or prospective or randomi#ed) adj3 (trial or study)).ti,ab. (31387)
65 (random$ adj7 (allocat$ or allot$ or assign$ or basis$ or divid$ or order$)).ti,ab. (20178)
66 ((singl$ or doubl$ or trebl$ or tripl$) adj7 (blind$ or mask$)).ti,ab. (11618)
67 (cross?over$ or (cross adj1 over$)).ti,ab. (3819)
68 or/57-67 (74722)
69 56 and 68 (477)
70 limit 69 to human (472)
71 exp nursing/ (5282)
72 exp nurses/ (10647)
73 (nurs$ adj25 practitioner$).ti,ab,sh. (1289)
74 or/71-73 (14760)
75 (cancer adj25 nurs$).ti,ab,sh. (568)
76 (breast adj25 nurs$).ti,ab,sh. (185)
77 (support$ adj25 (care or caring)).ti,ab,sh. (10511)
78 or/75-77 (11113)
79 74 or 78 (24904)
80 70 and 79 (22)
81 exp palliative care/ (2638)
82 exp hospice/ (1254)
83 (palliat$ or hospice$).ti,ab. (4097)
84 or/81-83 (4688)
85 70 and 84 (1)
86 from 85 keep 1 (1)
Appendix 5. Search strategy British Nursing Index (OVID 1984 - September 2005)
1. exp breast neoplasms/
2. exp “Neoplasms, Ductal, Lobular, and Medullary”/
3. exp Fibrocystic Breast Disease/
4. or/1-3
5. exp breast/
6. breast.tw.
7. 5 or 6
8. (breast adj milk).ti,ab,sh.
9. (breast adj tender$).ti,ab,sh.
10. or/8-9
11. 7 not 10
12. exp neoplasms/
13. 11 and 12
14. exp lymphedema/
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15. 14 and 11
16. (breast adj25 neoplasm$).ti,ab,sh.
17. (breast adj25 cancer$).ti,ab,sh.
18. (breast adj25 tumour$).ti,ab,sh.
19. (breast adj25 tumor$).ti,ab,sh.
20. (breast adj25 carcinoma$).ti,ab,sh.
21. (breast adj25 adenocarcinoma$).ti,ab,sh.
22. (breast adj25 sarcoma$).ti,ab,sh.
23. (breast adj50 dcis).ti,ab,sh.
24. (breast adj25 ductal).ti,ab,sh.
25. (breast adj25 infiltrating).ti,ab,sh.
26. (breast adj25 intraductal).ti,ab,sh.
27. (breast adj25 lobular).ti,ab,sh.
28. (breast adj25 medullary).ti,ab,sh.
29. or/16-28
30. 4 or 13 or 15 or 29
31. exp mastectomy/
32. 30 or 31
33. exp “ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES AND EQUIPMENT”/
34. 33 and 11
35. 34 or 32
36. exp mammary neoplasms/
37. (mammary adj25 neoplasm$).ti,ab,sh.
38. (mammary adj25 cancer$).ti,ab,sh.
39. (mammary adj25 tumour$).ti,ab,sh.
40. (mammary adj25 tumor$).ti,ab,sh.
41. (mammary adj25 carcinoma$).ti,ab,sh.
42. (mammary adj25 adenocarcinoma$).ti,ab,sh.
43. (mammary adj25 sarcoma$).ti,ab,sh.
44. (mammary adj50 dcis).ti,ab,sh.
45. (mammary adj25 ductal).ti,ab,sh.
46. (mammary adj25 infiltrating$).ti,ab,sh.
47. (mammary adj25 intraductal$).ti,ab,sh.
48. (mammary adj25 lobular).ti,ab,sh.
49. (mammary adj25 medullary).ti,ab,sh.
50. or/36-49
51. 35 or 50
52. exp breast self examination/
53. (breast adj25 self$).ti,ab,sh.
54. (breast adj25 screen$).ti,ab,sh.
55. exp mammography/
56. or/51-55
57. mammograph$.tw.
58. 57 and 11
59. 56 or 58
60. randomized controlled trial.pt.
61. controlled clinical trial.pt.
62. randomized controlled trials.sh.
63. random allocation.sh.
64. double-blind method.sh.
65. single blind method.sh.
66. or/60-65
67. clinical trial.pt.
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68. exp clinical trials/
69. (clin$ adj25 trial$).ti,ab.
70. ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).ti,ab.
71. placebos.sh.
72. placebo$.ti,ab.
73. random$.ti,ab.
74. research design.sh.
75. or/67-74
76. 66 or 75
77. 59 and 76
78. animals.mp. not human.sh. [mp=heading words, title]
79. 77 not 78
80. exp breast neoplasms/nu
81. exp nurse clinicians/
82. exp nurse’s role/
83. exp oncologic nursing/
84. exp nurse practitioner/
85. (cancer adj25 nurs$).ti,ab,sh.
86. (breast adj25 nurs$).ti,ab,sh.
87. (support$ adj25 (care or caring)).ti,ab,sh.
88. or/80-87
89. exp palliative care/
90. palliat$.ti,ab,sh.
91. or/89-90
92. 79 and 88
93. 79 and 91
Appendix 6. Search strategy LISA (OVID 13/04/2006)
(DE=“breast cancer”) or (neoplasm* and medullary*) or (fibrocystic near disease*) or (DE=“breast cancer”) or (neoplasm* and
medullary*) or (fibrocystic near disease*) or (breast$) not ((breast near milk) or (breast near tender) and (neoplasm$) or (lymphedema$)
and (DE=“breast cancer”) or (neoplasm* and medullary*) or (fibrocystic near disease*) or (breast$) not ((breast near milk) or (breast
near
tender) or (mastectom*) or (mammary near neoplasm*) or (breast near (self and examination) or (mammography)
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Medical Subject Headings (MeSH)
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